Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal Biosciences Investor Briefing, Sydney 13 July 2015

Opal Biosciences Investor Briefing, Sydney 13 July 2015 July 7, 2015 • Category • Author Name

Opal Biosciences Investor Briefing, Sydney 13 July 2015

Latest News

BioDiem Releases Half Year Results

March 20, 2019

BioDiem Half Year Results – 31 December 2018

Read More
BioDiem Half-year Financial Report – 31 December 2018

March 20, 2019

Half-year Financial Report – 31 December 2018

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions